2003
DOI: 10.1016/s0014-2999(03)02146-0
|View full text |Cite
|
Sign up to set email alerts
|

Chronic MCH-1 receptor modulation alters appetite, body weight and adiposity in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
107
2
3

Year Published

2005
2005
2018
2018

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 164 publications
(121 citation statements)
references
References 40 publications
5
107
2
3
Order By: Relevance
“…In the recent years, several MCH1-R antagonists such as T-226296 [27], SNAP-7941 [4] or the antagonist characterized by Bednarek et al [1], Shearman et al [23] and Mashiko et al [18] have been developed. These drugs significantly reduce MCH-induced increase in food intake when MCH is injected centrally and the antagonist is given orally (T-226296, [27]), intraperitoneally (SNAP-7941, [4]) or intracerebroventrically [18,23].…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…In the recent years, several MCH1-R antagonists such as T-226296 [27], SNAP-7941 [4] or the antagonist characterized by Bednarek et al [1], Shearman et al [23] and Mashiko et al [18] have been developed. These drugs significantly reduce MCH-induced increase in food intake when MCH is injected centrally and the antagonist is given orally (T-226296, [27]), intraperitoneally (SNAP-7941, [4]) or intracerebroventrically [18,23].…”
Section: Introductionmentioning
confidence: 99%
“…These drugs significantly reduce MCH-induced increase in food intake when MCH is injected centrally and the antagonist is given orally (T-226296, [27]), intraperitoneally (SNAP-7941, [4]) or intracerebroventrically [18,23].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations